Illustrated Neuropathologic Diagnosis of Alzheimer’s Disease

As of 2022, the prevalence of Alzheimer’s disease (AD) among individuals aged 65 and older is estimated to be 6.2 million in the United States. This figure is predicted to grow to 13.8 million by 2060. An accurate assessment of neuropathologic changes represents a critical step in understanding the...

Descripción completa

Detalles Bibliográficos
Autores principales: Doher, Nicholas, Davoudi, Vahid, Magaki, Shino, Townley, Ryan A., Haeri, Mohammad, Vinters, Harry V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366902/
https://www.ncbi.nlm.nih.gov/pubmed/37489360
http://dx.doi.org/10.3390/neurolint15030054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366902/
https://www.ncbi.nlm.nih.gov/pubmed/37489360
http://dx.doi.org/10.3390/neurolint15030054

Ejemplares similares